Cite
HARVARD Citation
Panetta, V. et al. (n.d.). P647 Post-marketing evaluation of reported adverse events of a multi-strain probiotic product confirms that change in manufacturing site had no impact on safety profile. Journal of Crohn's and colitis. pp. S534-S535. [Online].